CB vs CDTX · P/E 14, rev $59.40B vs rev $1.3M
Chubb Ltd (CB) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the CB and CDTX stock pages for the full models.
Not investment advice.